top of page
Abstract Dot Pattern

SCIENCE & RESEARCH

Clinical Research

This product has been used as an investigational product in the following clinical trials

Published clinical trials

AB-Free Kava reveals no signs of liver stress under the trial dose, regimen and participant eligibility criteria

Biomarkers associated with lung cancer risk were reduced among mmokers with no intention to quit upon 1 – 4 weeks of AB-Free Kava dietary supplementation (19, 24).

Addicted smokers with no intention to quit experienced reduced tobacco dependence and tobacco smoke exposure upon one-week kava dietary supplementation

Young male during intensive physical training maintained higher motivation to exercise with a 2-week AB-Free kava dietary supplementation

Clinical trials with the use of AB-Free Kava

Mayo clinical trial

A Study of Oral Kavalactones Effect on Nurses

View Study

NCT05381025

Kavalactones on Sleep and Cortisol in Healthy Special Forces Trainees

NCT05814055

The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

NCT05081882

Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava

NCT04565145

Biomarker Changes and Anxiolytic Effects-Phase 2 (KavaPK)

NCT07219186

Kava Aging and Mobility Study

NCT03843502

A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics (KavaPK)

NCT06213298

Effect of Kava on Anxiety and Stress in Cancer Survivors

bottom of page